Upregulation of asparagine synthetase fails to avert cell cycle arrest induced by L-asparaginase in TEL/AML1-positive leukaemic cells (original) (raw)
Oettgen HF, Old LJ, Boyse EA, Campbell HA, Philips FS, Clarkson BD et al. Inhibition of leukemias in man by L-asparaginase. Cancer Res 1967; 27: 2619–2631. CASPubMed Google Scholar
Jaffe N, Traggis D, Das L, Moloney WC, Hann HW, Kim BS et al. L-asparaginase in the treatment of neoplastic diseases in children. Cancer Res 1971; 31: 942–949. CASPubMed Google Scholar
Sutow WW, Garcia F, Starling KA, Williams TE, Lane DM, Gehan EA . L-asparaginase therapy in children with advanced leukemia. The Southwest Cancer Chemotherapy Study Group. Cancer 1971; 28: 819–824. ArticleCASPubMed Google Scholar
Tallal L, Tan C, Oettgen H, Wollner N, McCarthy M, Helson L et al. E. coli L-asparaginase in the treatment of leukemia and solid tumors in 131 children. Cancer 1970; 25: 306–320. ArticleCASPubMed Google Scholar
Zwaan CM, Kaspers GJ, Pieters R, Ramakers-Van Woerden NL, den Boer ML, Wunsche R et al. Cellular drug resistance profiles in childhood acute myeloid leukemia: differences between FAB types and comparison with acute lymphoblastic leukemia. Blood 2000; 96: 2879–2886. CASPubMed Google Scholar
Dubbers A, Wurthwein G, Muller HJ, Schulze-Westhoff P, Winkelhorst M, Kurzknabe E et al. Asparagine synthetase activity in paediatric acute leukaemias: AML-M5 subtype shows lowest activity. Br J Haematol 2000; 109: 427–429. ArticleCASPubMed Google Scholar
Codegoni AM, Biondi A, Conter V, Masera G, Rambaldi A, D'Incalci M . Human monocytic leukemia expresses low levels of asparagine synthase and is potentially sensitive to L-asparaginase. Leukemia 1995; 9: 360–361. CASPubMed Google Scholar
Pui C-H . Childhood Leukemias. First edn. Cambridge: Cambridge University Press, 1999.
Colletta G, Cirafici AM . TSH is able to induce cell cycle-related gene expression in rat thyroid cell. Biochem Biophys Res Commun 1992; 183: 265–272. ArticleCASPubMed Google Scholar
Greco A, Gong SS, Ittmann M, Basilico C . Organization and expression of the cell cycle gene, ts11, that encodes asparagine synthetase. Mol Cell Biol 1989; 9: 2350–2359. ArticleCASPubMedPubMed Central Google Scholar
Barbosa-Tessmann IP, Chen C, Zhong C, Siu F, Schuster SM, Nick HS et al. Activation of the human asparagine synthetase gene by the amino acid response and the endoplasmic reticulum stress response pathways occurs by common genomic elements. J Biol Chem 2000; 275: 26976–26985. CASPubMed Google Scholar
Hutson RG, Kitoh T, Moraga Amador DA, Cosic S, Schuster SM, Kilberg MS . Amino acid control of asparagine synthetase: relation to asparaginase resistance in human leukemia cells. Am J Physiol 1997; 272: C1691–C1699. ArticleCASPubMed Google Scholar
Barbosa-Tessmann IP, Chen C, Zhong C, Schuster SM, Nick HS, Kilberg MS . Activation of the unfolded protein response pathway induces human asparagine synthetase gene expression. J Biol Chem 1999; 274: 31139–31144. ArticleCASPubMed Google Scholar
Siu F, Chen C, Zhong C, Kilberg MS . CCAAT/enhancer-binding protein-beta is a mediator of the nutrient-sensing response pathway that activates the human asparagine synthetase gene. J Biol Chem 2001; 276: 48100–48107. ArticleCASPubMed Google Scholar
Aslanian AM, Fletcher BS, Kilberg MS . Asparagine synthetase expression alone is sufficient to induce l-asparaginase resistance in MOLT-4 human leukaemia cells. Biochem J 2001; 357: 321–328. ArticleCASPubMedPubMed Central Google Scholar
Ramakers-van Woerden NL, Pieters R, Loonen AH, Hubeek I, van Drunen E, Beverloo HB et al. TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia. Blood 2000; 96: 1094–1099. CASPubMed Google Scholar
Wang L, Hiebert SW . TEL contacts multiple co-repressors and specifically associates with histone deacetylase-3. Oncogene 2001; 20: 3716–3725. ArticleCASPubMed Google Scholar
Zuna J . The role of TEL and AML1 genes in the pathogenesis of hematologic malignancies. Cas Lek Cesk 2001; 140: 131–137. CASPubMed Google Scholar
Fenrick R, Amann JM, Lutterbach B, Wang L, Westendorf JJ, Downing JR et al. Both TEL and AML-1 contribute repression domains to the t(12;21) fusion protein. Mol Cell Biol 1999; 19: 6566–6574. ArticleCASPubMedPubMed Central Google Scholar
Hiebert SW, Lutterbach B, Amann J . Role of co-repressors in transcriptional repression mediated by the t(8;21), t(16;21), t(12;21), and inv(16) fusion proteins. Curr Opin Hematol 2001; 8: 197–200. ArticleCASPubMed Google Scholar
Zuna J, Hrusak O, Kalinova M, Muzikova K, Stary J, Trka J . TEL/AML1 positivity in childhood ALL: average or better prognosis? Czech Paediatric Haematology Working Group. Leukemia 1999; 13: 22–24. ArticleCASPubMed Google Scholar
Zuna J, Hrusak O, Kalinova M, Muzikova K, Stary J, Trka J . Significantly lower relapse rate for TEL/AML1-positive ALL. Leukemia 1999; 13: 1633. ArticleCASPubMed Google Scholar
Loh ML, Silverman LB, Young ML, Neuberg D, Golub TR, Sallan SE et al. Incidence of TEL/AML1 fusion in children with relapsed acute lymphoblastic leukemia. Blood 1998; 92: 4792–4797. CASPubMed Google Scholar
Stams WA, den Boer ML, Beverloo HB, Meijerink JP, Stigter RL, van Wering ER et al. Sensitivity to L-asparaginase is not associated with expression levels of asparagine synthetase in t(12;21)+ pediatric ALL. Blood 2003; 101: 2743–2747. ArticleCASPubMed Google Scholar
Hrusak O, Trka J, Zuna J, Houskova J, Bartunkova J, Stary J . Aberrant expression of KOR-SA3544 antigen in childhood acute lymphoblastic leukemia predicts TEL-AML1 negativity. The Pediatric Hematology Working Group in the Czech Republic. Leukemia 1998; 12: 1064–1070. ArticleCASPubMed Google Scholar
van Dongen JJ, Macintyre EA, Gabert JA, Delabesse E, Rossi V, Saglio G et al. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 concerted action: investigation of minimal residual disease in acute leukemia. Leukemia 1999; 13: 1901–1928. ArticleCASPubMed Google Scholar
Trka J, Zuna J, Hrusak O, Michalova K, Muzikova K, Kalinova M et al. No evidence for MLL/AF4 expression in normal cord blood samples. Blood 1999; 93: 1106–1107, discussion 1108-10. CASPubMed Google Scholar
Chomczynski P, Sacchi N . Single-step method of RNA isolation by acid guanidinium thiocyanate–phenol–chloroform extraction. Anal Biochem 1987; 162: 156–159. ArticleCASPubMed Google Scholar
Zuna J, Muzikova K, Madzo J, Krejci O, Trka J . Temperature non-homogeneity in rapid airflow-based cycler significantly affects real-time PCR. Biotechniques 2002; 33: 508 510, 512. ArticleCASPubMed Google Scholar
Muller HJ, Beier R, Loning L, Blutters-Sawatzki R, Dorffel W, Maass E et al. Pharmacokinetics of native Escherichia coli asparaginase (Asparaginase medac) and hypersensitivity reactions in ALL-BFM 95 reinduction treatment. Br J Haematol 2001; 114: 794–799. ArticleCASPubMed Google Scholar
Aslanian AM, Kilberg MS . Multiple adaptive mechanisms affect asparagine synthetase substrate availability in asparaginase-resistant MOLT-4 human leukaemia cells. Biochem J 2001; 358: 59–67. ArticleCASPubMedPubMed Central Google Scholar
Muller HJ, Boos J . Use of L-asparaginase in childhood ALL. Crit Rev Oncol Hematol 1998; 28: 97–113. ArticleCASPubMed Google Scholar
Horig H, Spagnoli GC, Filgueira L, Babst R, Gallati H, Harder F et al. Exogenous glutamine requirement is confined to late events of T cell activation. J Cell Biochem 1993; 53: 343–351. ArticleCASPubMed Google Scholar
Chang WK, Yang KD, Shaio MF . Lymphocyte proliferation modulated by glutamine: involved in the endogenous redox reaction. Clin Exp Immunol 1999; 117: 482–488. ArticleCASPubMedPubMed Central Google Scholar
Roth E, Oehler R, Manhart N, Exner R, Wessner B, Strasser E et al. Regulative potential of glutamine – relation to glutathione metabolism. Nutrition 2002; 18: 217–221. ArticleCASPubMed Google Scholar
Madzo J, Zuna J, Muzikova K, Kalinova M, Krejci O, Hrusak O et al. Slower molecular response to treatment predicts poor outcome in patients with TEL/AML1 positive acute lymphoblastic leukemia: prospective real-time quantitative reverse transcriptase-polymerase chain reaction study. Cancer 2003; 97: 105–113. ArticleCASPubMed Google Scholar